• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】13694

【品名】(acetoxy)methyl (2S,5R,6S)-6-bromo-6-[(1R)-1-hydroxyethyl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate

【CA登记号】

【 分 子 式 】C13H18BrNO6S

【 分 子 量 】396.25906

【元素组成】C 39.4% H 4.58% Br 20.16% N 3.53% O 24.23% S 8.09%

与该中间体有关的原料药合成路线共 1 条

合成路线1

该中间体在本合成路线中的序号:(V)

FCE 22891 in the ester prodrug formulation of FCE 22101. Reaction of the latter (sodium salt) with acetoxymethyl bromide (DMF) is the traditional synthetic route to FCE 22891. This route is also the preferred one as long as manufacturing involves both compounds (the reverse process, conversion of FCE 22891 into the parent acid FCE 22101, can be conveniently realized by enzymic hydrolysis catalyzed by porcine liver esterase or lipase A6 from Aspergillus niger). Direct synthesis of FCE 22891 can be performed using two major strategies. The total synthetic approaches start from chiral amino or hydroxy acids (threonine, 3-hydroxybutyric acid) and have (3R,4R)-4-acetoxy-3-[(R)-1-hydroxyethyl]-2-oxo-1H-azetidine (Ia) or its 4-benzoyloxy analogue (Ib), usually protected as the tert-butyldimethylsilyl ethers, as common intermediates. These compounds, in particular (Ia), can also be found on the market (Kaneka). Reaction of either (Ia) or (Ib) with the sodium salt of 2-carbamoyloxyethanethioic acid gives the azetidinone thiolester (II), which is condensed with acetoxymethyl oxalyl chloride. Reductive carbonyl condensation (triethyl phosphite, refluxing toluene) and desilylation (tetrabutylammonium fluoride buffered with acetic acid) affords FCE 22891. The hemisynthetic route utilizes 6-APA as a chiral template. Introduction of the alpha-hydroxyethyl chain on the penam nucleus is satisfactorily achieved by deaminative bromination, metal exchange with EtMgBr, aldol reaction (acetaldehyde, THF, -70 C) and reductive dehalogenation (Zn-AcOH), MeOH, -10 C). During this process, the acetoxymethyl promoiety characterizing the final product is conveniently introduced. According to an original procedure, beta-eliminative ring opening of the thiazolidine ring (AgCl/DBN) and in situ acylation of the intermediate silver mercaptide with carbamoyloxyacetyl chloride affords the key azetidone thioester (VII). Ozonolysis (CH2Cl2, -50 C) and reductive carbonyl condensation completes the sequence, without resorting to protective groups other than trimethylsilyl, which is removed at the end by simple acidic work-up.

1 Franceschi, G.; Foglio, M.; Alpegiani, M.; Battistini, C.; Bedeschi, A.; Perrone, E.; Zarini, F.; Arcamone, F.; Della Bruna, C.; Sanfilippo, A.; Synthesis and biological properties of sodium (5R,6S, 8R)-6alpha-hydroxyethyl-2-carbamoyloxymethyl-2-penem-3-carboxylate (FCE 22101) and its orally absorbed esters FCE 22553 and FCE 22891. J Antibiot 1983, 36, 7, 938-41.
2 Perrone, E.; FCE 22891. Drugs Fut 1991, 16, 4, 313.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
63804 2-[(aminocarbonyl)oxy]ethanethioic S-acid C3H5NO3S 详情 详情
63805 [(2-chloro-2-oxoacetyl)oxy]methyl acetate C5H5ClO5 详情 详情
(Ia) 11687 (2R,3R)-3-((1R)-1-[[tert-butyl(dimethyl)silyl]oxy]ethyl)-4-oxoazetanyl acetate C13H25NO4Si 详情 详情
(Ib) 13689 (2R,3R)-3-((1R)-1-[[tert-butyl(dimethyl)silyl]oxy]ethyl)-4-oxoazetidinyl benzoate C18H27NO4Si 详情 详情
(IIIa) 13691 (acetoxy)methyl 2-[(2R,3S)-2-([2-[(aminocarbonyl)oxy]acetyl]sulfanyl)-3-(1-[[tert-butyl(dimethyl)silyl]oxy]ethyl)-4-oxoazetidinyl]-2-oxoacetate C19H30N2O10SSi 详情 详情
(IIIb) 13692 (acetoxy)methyl 2-((2R,3S)-2-([2-[(aminocarbonyl)oxy]acetyl]sulfanyl)-4-oxo-3-[1-[(trimethylsilyl)oxy]ethyl]azetidinyl)-2-oxoacetate C16H24N2O10SSi 详情 详情
(VIa) 13695 (acetoxy)methyl (2S,5R,6S)-6-[(1R)-1-hydroxyethyl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate C13H19NO6S 详情 详情
(VIb) 13696 (acetoxy)methyl (2S,5R,6S)-3,3-dimethyl-7-oxo-6-[(1R)-1-[(trimethylsilyl)oxy]ethyl]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate C16H27NO6SSi 详情 详情
FCE 22101 63806 sodium 3-{[(aminocarbonyl)oxy]methyl}-6-(1-hydroxyethyl)-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate C10H11N2NaO6S 详情 详情
(II) 13690 S-[(2R,3S)-3-((1R)-1-[[tert-butyl(dimethyl)silyl]oxy]ethyl)-4-oxoazetidinyl] 2-[(aminocarbonyl)oxy]ethanethioate C14H26N2O5SSi 详情 详情
(IV) 13693 (acetoxy)methyl (2S,5R)-6,6-dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate C11H13Br2NO5S 详情 详情
(V) 13694 (acetoxy)methyl (2S,5R,6S)-6-bromo-6-[(1R)-1-hydroxyethyl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate C13H18BrNO6S 详情 详情
6-APA 32631 (2S,5R,6R)-6-amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (+)-6-Aminopenicillanic acid; 6-APA 551-16-6 C8H12N2O3S 详情 详情
(VII) 13697 (acetoxy)methyl 2-[(2R,3S)-2-([2-[(aminocarbonyl)oxy]acetyl]sulfanyl)-3-[(1R)-1-methyl-2-(trimethylsilyl)ethyl]-4-oxoazetidinyl]-3-methyl-2-butenoate C20H32N2O8SSi 详情 详情
Extended Information